Related Experiment Video
Updated: Feb 5, 2026

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
Suppression of long noncoding RNA NCK1-AS1 increases chemosensitivity to cisplatin in cervical cancer
Wei-Yi Zhang1, Yin-Jiao Liu1, Yan He1
1Department of Gynecology and Obstetrics, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.
Abstract:
Cervical cancer remains a serious health problem till now, with nearly 500,000 women cases diagnosed each year around the world. Long noncoding RNA (lncRNA) is a novel class of RNA transcripts (>200 nucleotides in length) participating in gene transcription, cell proliferation, differentiation, and drug resistance. This study aimed to explore the regulatory relationship among lncRNA NCK1-AS1, miR-134-5p, and MutS protein homolog 2 (MSH2), so that the resistance against cisplatin in cervical cancer treatment could be better understood. Comprehensive lncRNA profiling analysis was performed to screen lncRNAs differentially expressed in cervical cancer. The expression patterns of miR-134-5p, NCK1-AS1, and MSH2 were evaluated in cancerous tissues and adjacent normal tissues obtained from 75 cervical cancer patients. Subsequently, anti-NCK1-AS1 small interfering RNA, miR-134-5p mimics, and miR-134-5p inhibitors were transfected into cervical cancer cells, and the effects of these transcripts on cisplatin resistance and cell apoptosis were investigated. The regulatory relationship among NCK1-AS1, miR-134-5p, and MSH2 was identified using a dual-luciferase reporter gene assay, and the results were further validated by RNA pull-down and RNA immunoprecipitation assays. Based on the microarray data of GSE63514 and GSE27678, NCK1-AS1 was upregulated in cervical cancer. Increased expression of NCK1-AS1, MSH2, and decreased expression of miR-134-5p were observed in cervical cancer tissues. In addition, NCK1-AS1 competitively bound to miR-134-5p to regulate MSH2. Therefore, si-NCK1-AS1 and miR-134-5p mimic both reduced MSH2 activity and increased cisplatin-induced apoptosis in cervical cancer cells. Taken together, NCK1-AS1 may become a novel target in improving the chemotherapeutic response and survival of cervical cancer patients.
Insights
Long noncoding RNA NCK1-AS1 promotes cisplatin resistance in cervical cancer by regulating miR-134-5p and MSH2. Targeting NCK1-AS1 may improve treatment outcomes and patient survival.
Area of Science:
- Molecular Biology
- Oncology
- RNA Biology
Background:
- Cervical cancer is a significant global health issue, with nearly 500,000 new cases annually.
- Long noncoding RNAs (lncRNAs) are emerging as key regulators in various cellular processes, including gene transcription and drug resistance.
- Understanding the molecular mechanisms underlying cisplatin resistance in cervical cancer is crucial for improving therapeutic efficacy.
Purpose of the Study:
- To investigate the regulatory network involving lncRNA NCK1-AS1, miR-134-5p, and MutS protein homolog 2 (MSH2) in cervical cancer.
- To elucidate the role of this network in conferring resistance to cisplatin chemotherapy.
- To explore NCK1-AS1 as a potential therapeutic target for enhancing cervical cancer treatment.
Main Methods:
- lncRNA profiling analysis to identify differentially expressed lncRNAs in cervical cancer.
- Quantitative evaluation of NCK1-AS1, miR-134-5p, and MSH2 expression in patient tissues and cell lines.
- Functional assays including transfection with small interfering RNA (siRNA) and mimics/inhibitors, dual-luciferase reporter assays, RNA pull-down, and RNA immunoprecipitation.
Main Results:
- NCK1-AS1 was found to be upregulated in cervical cancer tissues.
- Increased expression of NCK1-AS1 and MSH2, with decreased miR-134-5p, was observed in cancerous tissues.
- NCK1-AS1 directly interacts with miR-134-5p, regulating MSH2 expression. Inhibition of NCK1-AS1 or augmentation of miR-134-5p reduced MSH2 activity and enhanced cisplatin-induced apoptosis.
Conclusions:
- The NCK1-AS1/miR-134-5p/MSH2 axis plays a critical role in regulating cisplatin resistance in cervical cancer.
- NCK1-AS1 acts as a molecular sponge for miR-134-5p, leading to increased MSH2 expression and chemoresistance.
- Targeting NCK1-AS1 presents a promising strategy for overcoming cisplatin resistance and improving patient survival in cervical cancer.
Related Concept Videos
Increasing Function
RNA Stability
Increased Body Temperature
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Structure
The basic structure of RNA consists of a five-carbon sugar and one of four nitrogenous bases. Although most RNA is single-stranded, it can form complex secondary and tertiary structures. Such structures play essential roles in the regulation of transcription and translation.
Different Types of RNA Have the Same Basic Structure
There are three main types of ribonucleic acid (RNA): messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). All three RNA types consist of a...

